P1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE L... by A. McMillan, C. Haioun, J.-M. Sancho, A. Viardot, A. Rodriguez Izquierdo, E. M. Donato Martin, A. M. García-Sancho, J. Sandoval-Sus, H. Tilly, E. Vandenberghe, J. Hirata, P. Choudhry, Y. M. Chang, L. Musick, M. Matasar

Get full text

P1192: ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL by Y. Song, J. Jin, H. Tilly, H. Zhang, J. Cao, J. Feng, L. Zhang, S. Rai, H. Goto, Y. Terui, W. S. Kim, H.-J. Shin, J.-P. Gau, C.-H. Tsai, J. P. Sharman, L. Bu, J. Hirata, C. Lee, K. Izutsu, J. Zhu

Get full text

P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMENTS IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL by F. Morschhauser, Y. Jiang, F. Jardin, A. F. Herrera, L. H. Sehn, C. Herbaux, C. Flowers, T. Phillips, A. López Guillermo, C. Diefenbach, G. P. Gregory, A. Kim, A. M. Barbui, S. Balasubramanian, W. Harris, J. Hirata, J. N. Paulson, C. Lee, G. Lenz

Get full text

P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY by M. Trněný, L. Fogliatto, F. Gardner, I. Flinn, J.-F. Larouche, C. Haioun, M. Canales, H. Goto, R. Hajek, G. Salles, J. Qiu, A. Campinha-Bacote, M. Yan, R. Kothari, G. Man, D. Sahin, J. Hirata, C. Lee, H. Tilly, C. Flowers

Get full text